373 results on '"Fireman B"'
Search Results
2. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study
3. Screening differences and risk of cervical cancer in inflammatory bowel disease
4. Do vaccines increase the risk of Guillain-Barre syndrome?: O374
5. Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results
6. EFFECTIVENESS OF LIVE ZOSTER VACCINE IN PREVENTING POSTHERPETIC NEURALGIA (PHN)
7. Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results.
8. Network Meta-Analysis Using Observational Data From Distributed Health Data Networks: A Conceptual Framwork And Illustrative Example
9. B1-4: eCare for Moods (TM), A Patient-centered, Web-delivered Self-management and Care Management Program for Recurrent Depression: Results from Randomized Trial
10. PRM208 - Network Meta-Analysis Using Observational Data From Distributed Health Data Networks: A Conceptual Framwork And Illustrative Example
11. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators.
12. Effectiveness of pertussis vaccines for adolescents and adults: case-control study
13. Lack of Association of Guillain-Barre Syndrome With Vaccinations
14. CB7-02: Medicare Part D Cost-sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems
15. Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010
16. Rowhani-Rahbar et al. Respond to "Immunization and Bell's Palsy in Children"
17. Immunization and Bell's Palsy in Children: A Case-Centered Analysis
18. C-A5-03: Rapid Estimates of the Costs of Diagnosing Lung Cancers
19. C-C5-01: Drug Safety Data Mining with a Tree-Based Scan Statistic
20. C-B5-02: H1N1 Vaccine Safety Monitoring in the Vaccine Safety Datalink Project: New Challenges and Useful Lessons
21. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators
22. Phase II trial of nab-paclitaxel as first-line therapy of hormone refractory metastatic prostate cancer (HRPC)
23. Abstract C-C1-04: The Effectiveness of Diabetes Care Management in a Large, Integrated Delivery System: a TRIAD Study
24. Glycemic Status and Risk of Prostate Cancer
25. Risk of cervical cancer in IBD patients by IBD medication use
26. PAA9 THE EFFECTS OF GENERIC-ONLY DRUG COVERAGE ON INHALED CORTICOSTEROID EXPENDITURES AND USE
27. Value of the Sagittal Abdominal Diameter in Coronary Heart Disease Risk Assessment: Cohort Study in a Large, Multiethnic Population
28. PHP19 PRESCRIPTION DRUGS AND ANNUAL BENEFIT CAPS—DO PATIENTS ANTICIPATE EXCEEDING THE CAP?
29. FMI PRESCRIPTION DRUG COST-SHARING AND ANTICOAGULANT DRUG USE-UNINTENDED EFFECTS OF THINNER BENEFITS
30. Drinking patterns and problems of the "stably insured": a study of the membership of a health maintenance organization.
31. Pharmacotherapy for OCD in a pre-paid health plan over time
32. Breast Cancer Survival and Treatment in Health Maintenance Organization and Fee-for-Service Settings
33. P.3.056 Recognition and treatment of obsessive compulsive disorder in a pre-paid health plan: Does adequate treatment reduce costs?
34. SAFETY AND IMMUNOGENICITY OF HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE(Wyeth-Lederle) IN INFANCY. 986
35. Safety, Immunogenicity, and Efficacy in Infancy of Oligosaccharide Conjugate Haemophilus influenzae Type b Vaccine in a United States Population: Possible Implications for Optimal Use
36. Meaningful variation in performance: a systematic literature review.
37. Meaningful variation in performance: what does variation in quality tell us about improving quality?
38. Validation of an algorithm for categorizing the severity of hospital emergency department visits.
39. Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
40. Maternal transfers and hospital perinatal mortality rates.
41. Treatment intensification and risk factor control: toward more clinically relevant quality measures.
42. Relationships among depression, chronic pain, chronic disabling pain, and medical costs.
43. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.
44. Early experiences with e-health services (1999-2002): promise, reality, and implications.
45. Comorbid depression, chronic pain, and disability in primary care.
46. Care-seeking behavior in response to emergency department copayments.
47. Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs.
48. Use of e-health services between 1999 and 2002: a growing digital divide.
49. Can disease management reduce health care costs by improving quality? We cannot reduce costs by improving quality unless treatments for the chronically ill are themselves cost-saving.
50. Cost-sharing: patient knowledge and effects on seeking emergency department care.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.